Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Here’s how you can help maintain a healthy gut microbiome and lower your risk of colorectal cancer.
A study in mice found that engineered "bacterial biosensors” could detect DNA shed by colorectal cancer tumors.
These bacteria can promote the development of colorectal cancer by damaging DNA and hindering the body’s immune system.
Preclinical findings highlight bacterial groups that influence the risk for graft-versus-host-disease in blood cancer transplant patients.
People with preclinical Alzheimer’s disease had markedly different assemblages of gut bacteria.
Researchers discover that specific gut bacteria can affect how well PD-1 checkpoint inhibitors work.
Disturbed gut bacteria may contribute to slower tissue regeneration after liver surgery or other injury.
Cancer patients who engaged in regular moderate exercise had a greater diversity of bacteria in their intestines and reduced inflammation.
The findings, if confirmed in humans, suggest strategies to help encourage people to exercise.
A person’s individual gut microbiome may influence how well chemotherapy works and the likelihood of side effects.
Two studies at the intersection of cancer and microbiome research explore how bacteria help tumors grow and spread.
Alessandro Mannuci, MD, discusses the relation between Lynch Syndrome, colorectal cancer and the microbiome.
Cancer drugs called immune checkpoint inhibitors can cause itching and painful skin rashes. But what triggers these side effects?
People with melanoma can modify lifestyle factors such as diet, stress and the gut microbiome to improve treatment outcomes.
Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.
Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.